> During 1,915,120 person-years of observation, 218 persons developed NAION. Semaglutide 51 exposure associated with a higher incidence rate (0·228 vs 0·093 per 1000 person-years, p<0·001) 52 and independently predicted a higher risk of upcoming NAION (HR 2·19, 95% confidence interval 53 1·54-3·12), even when multiple other factors were taken into account.
> In this cohort study conducted in Denmark and Norway, use of semaglutide was associated with an increased risk of NAION; the pooled hazard ratio was 2.81 (95% confidence interval (CI) 1.67 to 4.75) and the incidence rate difference (absolute risk increase) was +1.41 (95% CI +0.53 to +2.29) NAION events per 10,000 person-years. The finding was consistent across sensitivity and supplementary analysis.
> Both Danish studies show that the risk of developing NAION for the individual patient receiving treatment with Ozempic is only 0.2 per thousand per year, which is fortunately significantly lower than in the American study. NAION is a relatively rare condition, and the extra risk is therefore low. The researchers estimate that for every 10,000 people treated in a year, between 1.5 and 2.5 extra cases will be seen.
Sadly it's still relative, and they still leave you the mental maths to work out the natural frequencies.
You are right in that the mechanisms may not be well-understood. This does warrant further study, as the paper concludes.
Some are. Some are simply prescribed because the patient asks for them.
> even if little is known about their mechanism.
I wouldn't take it unless my condition was immediately life threatening and there were no other medications available. There are very few classes of treatment that fall within these parameters.
Your chances of being hit by a meteorite are _at most_ 1 in 1,000,000.
My happiness would not extend across several orders of magnitude like that, but perhaps, some people just need the $10k more than I would.